leukemogenicity
leukemic
leukemogenically
leukemogenic
acute lymphoblastic leukemia
leukaemogenesis
acute leukemia
leukaemic
leukemogenesis
chronic leukemia
promyeloleukemia
nonleukemic
lymphoblastic leukemia
erythroleukosis
acute lymphocytic leukemia
acute myeloid leukemia
nonleukemia
acute myelocytic leukemia
erythroleukemic
histiocytic leukemia
monocytic leukemia
preleukemia
histiocytic leukaemia
monocytic leukaemia
monoblastic leukaemia
monoblastic leukemia
leukoblastic
antileukemic
erythroleukemia
myeloid leukemia
chronic myelocytic leukemia
ponatinib
leukemoid
leucoblastoma
nonleukemogenic
antileukemia
leukocytopenia
pseudoleukaemia
chronic lymphocytic leukemia
hematogone
CD135
monocytosis
hairy cell
lenzilumab
venetoclax
myeloleukemia
idelalisib
lymphocytotoxicity
aleukia
amoebocyte
lymphocytic leukemia
chromism
talacotuzumab
cytotoxically
IGHV
lumiliximab
leukopenic
lymphotoxicity
thioguanine
leukemid
smudge cell
Fanconi anemia
mogamulizumab
lymphogenically
cyclogenetic
alemtuzumab
chemotyping
leukocytoclasia
chloraminophene
hemangiocyte
cytotoxicological
myeloblast
cytoablative
bivalent
neochromosome
chromatinizable
cytogenotoxicity
karyotin
chromidium
chromo-
ubenimex
lymphoblast
tyrosine kinase inhibitor
leukocytic
cytoplasmically
lymphologically
cytoimmunologically
cytoembryological
lymphogenously
midostaurin
ofatumumab
cytolemmal
sialophorin
pegaspargase
leukolysis